Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Nationwide Children's Hospital
Hoffmann-La Roche
Stemline Therapeutics, Inc.
Hoffmann-La Roche
Neonc Technologies, Inc.
Australian & New Zealand Children's Haematology/Oncology Group